IP Library Granted Patent US 7,595,333
Granted Patent B2
US 7,595,333 · App. 10/717,738 · Granted Sep 29, 2009

Agent for improving acidosis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,595,333
App. No.
10/717,738
Granted
Sep 29, 2009
Kind
B2
Abstract

An agent for improving ketosis which comprises an insulin sensitizer, which has an excellent action and low toxicity.

Claims (15)

1. A method of treating acidosis in a mammal in need thereof which comprises administering to said mammal an effective amount of an insulin sensitizer in combination with insulin, wherein the insulin sensitizer is selected from pioglitazone or a salt thereof;

wherein said acidosis is acidosis caused by metformin.

2. A method of treating acidosis in a mammal in need thereof, which comprises administering to said mammal an effective amount of an insulin sensitizer selected from pioglitazone or a salt thereof;

wherein said acidosis is acidosis caused by metformin.

3. The method of claim 1 wherein the insulin sensitizer is pioglitazone hydrochloride.

4. The method of claim 2 wherein the insulin sensitizer is pioglitazone hydrochloride.

5. A method of treating acidosis in a mammal in need thereof which comprises administering to said mammal an effective amount of an insulin sensitizer in combination with insulin;

wherein:

the insulin sensitizer is selected from pioglitazone or a salt thereof;

said acidosis is diabetic acidosis; and

said mammal has type II diabetes.

6. A method of treating acidosis in a mammal in need thereof, which comprises administering to said mammal an effective amount of an insulin sensitizer selected from pioglitazone or a salt thereof;

wherein:

said acidosis is diabetic acidosis; and

said mammal has type II diabetes.

Assignments (1)
CHANGE OF NAME Recorded Jun 2, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 018917/0406 →